
Nanoscribe GmbH
Nanoscribe GmbH
3 Projects, page 1 of 1
assignment_turned_in Project2017 - 2024Partners:Pfizer Global R and D, Texas Instruments (United States), Nanoscribe GmbH, Rogers Corporation, AWE +13 partnersPfizer Global R and D,Texas Instruments (United States),Nanoscribe GmbH,Rogers Corporation,AWE,University of Nottingham,AstraZeneca (United Kingdom),NTU,Rogers Corporation,AstraZeneca plc,Defence Science and Technology Laboratory,Nanoscribe GmbH,Pfizer (United Kingdom),Oce Technologies BV,Atomic Weapons Establishment,Texas Instruments Inc,Canon (Netherlands),Defence Science & Tech Lab DSTLFunder: UK Research and Innovation Project Code: EP/P031684/1Funder Contribution: 5,852,470 GBPTwenty-first century products demand a new toolset of manufacturing techniques and materials; next generation multifunctional Additive Manufacturing (AM) is one such key tool. As an enabler for new smart, cost-effective, functional 3D heterogeneous devices, products and advanced materials, it will be an essential instrument for future industrial applications and advanced research across a wide spectrum of disciplines and sectors. To accelerate next-generation AM, we have established a multi-institution, multidisciplinary team which spans both basic/applied sciences and engineering and involves collaborations with two leading international research groups and eight multinational industry partners. Our vision is to establish controlled next generation multifunctional AM and translate this to industry and researchers. Initially focussing on novel electronic and pharmaceutical/healthcare applications, we aim to move beyond single material AM by exploiting the potential to deposit multiple materials contemporaneously for the delivery of spatially resolved function and structure in three dimensions (3D). Owing to potentially radical differences in physical state, chemistry and compatibility, our primary challenge is at the interface of the deposited materials. This programme will focus on overcoming the challenges of spatially controlled co-deposition of dissimilar materials in 3D and we will establish new understanding and methods of both modelling and controlling co-deposition. Exploitation of our findings will be undertaken through higher TRL schemes with our network of research and industrial partners and the wider innovation ecosystem through existing and future projects.
All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::668122e523900c141a0cb366a59f1aab&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eumore_vert All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::668122e523900c141a0cb366a59f1aab&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.euassignment_turned_in Project2017 - 2022Partners:Intuitive Surgical Inc, Mauna Kea Technologies (France), Medtronic, Mauna Kea Technologies, Nanoscribe GmbH +20 partnersIntuitive Surgical Inc,Mauna Kea Technologies (France),Medtronic,Mauna Kea Technologies,Nanoscribe GmbH,Intel Corporation (UK) Ltd,Beating Bowel Cancer,British Lung Foundation,Tescan UK Ltd,Intel UK,TESCAN UK,Intuitive Surgical Inc,Biocompatibles (United Kingdom),Imperial College London,Breakthrough Breast Cancer,Hansen Medical Inc,Medtronic (United States),Karl Storz GmbH & Co. KG,Breast Cancer Now,Biocompatibles UK Ltd,Karl Storz (Germany),Nanoscribe GmbH,British Lung Foundation,Beating Bowel Cancer,Auris Health (United States)Funder: UK Research and Innovation Project Code: EP/P012779/1Funder Contribution: 6,236,360 GBPAs minimally invasive surgery is being adopted in a wide range of surgical specialties, there is a growing trend in precision surgery, focussing on early malignancies with minimally invasive intervention and greater consideration on patient recovery and quality of life. This requires the development of sophisticated micro-instruments integrated with imaging, sensing, and robotic assistance for micro-surgical tasks. This facilitates management of increasingly small lesions in more remote locations with complex anatomical surroundings. The proposed programme grant seeks to harness different strands of engineering and clinical developments in micro-robotics for precision surgery to establish platform technologies in: 1) micro-fabrication and actuation; 2) micro-manipulation and cooperative robotic control; 3) in vivo microscopic imaging and sensing; 4) intra-operative vision and navigation; and 5) endoluminal platform development. By using endoluminal micro-surgical intervention for gastrointestinal, cardiovascular, lung and breast cancer as the exemplars, we aim to establish a strong technological platform with extensive industrial and wider academic collaboration to support seamless translational research and surgical innovation that are unique internationally.
All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::b15cd6a2d9f979cc331d91789e4f0432&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eumore_vert All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::b15cd6a2d9f979cc331d91789e4f0432&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.euassignment_turned_in Project2024 - 2029Partners:Technical University of Bari, Polytechnic University of Milan, Durham University, University of Birmingham, University of Bristol +101 partnersTechnical University of Bari,Polytechnic University of Milan,Durham University,University of Birmingham,University of Bristol,Luceda Photonics,Lumiphase AG,Zero Point Motion Ltd,CNRS,UMA,Scottish Enterprise,National Quantum Computing Centre,Pointcloud,University of Sheffield,Siloton Ltd,Technology Scotland,University of Strathclyde,Aquark Technologies,University of Aberdeen,Tyndall National Institute,Light Trace Photonics Ltd,Silicon Catalyst UK Ltd,Microsoft,ePIXfab,Seagate (United Kingdom),Camgraphic Ltd,Loughborough University,Consorzio Nazionale Interuniversitario per le Telecomunicazioni,InSpek,CARDIFF UNIVERSITY,Tech Tour Europe,Cadence Design Systems Ltd,Sivers Photonics Ltd,University of York,Wave Photonics,Resolute Photonics (UK) Ltd,The University of Manchester,Swansea University,National Physical Laboratory,Europractice,QUB,Trellisense,Photonics Leadership Group,UNIVERSITY OF CAMBRIDGE,Solent LEP,Google (United States),Aston University,Compugraphics (United Kingdom),PsiQuantum Ltd,UV,Lightelligence,SENKO Advanced Components,Octopus Ventures,PhotonIP,Digital Catapult,Quantinuum,University of Southampton,TOSHIBA EUROPE LIMITED,G&H Photonics,Xanadu,Cambridge Consultants (United Kingdom),CompoundTek Pte Ltd,University of Twente,CMC Microsystems,Akhetonics,Leonardo,University of Salford,iPronics Programmable Photonics,Qinetiq (United Kingdom),Renishaw plc (UK),University of Huddersfield,Nanyang Technological University,Bay Photonics Ltd,Photronics (U K) Ltd,Compound Semiconductor App. Catapult,Oxford Instruments (United Kingdom),IBM Research GmBh,Rockley Photonics Limited (UK),Synopsys (Northern Europe Ltd.),University of Pavia,Elforlight (United Kingdom),Plasmore Srl,Heriot-Watt University,IQE PLC,McMaster University,Stanford University,CTU,Optalysys Ltd,University of St Andrews,Imperial College London,PICadvanced,Aberystwyth University,Newcastle University,UNIVERSITY OF EXETER,Lancaster University,Intel Corporation (UK) Ltd,Duality Quantum Photonics Ltd,Ludwig Maximilian University of Munich,TU Delft,British Telecommunications plc,Alter Technology UK Ltd,Institute of High Performance Computing,University of Nottingham,Royal Holloway University of London,Nanoscribe GmbH,BioherentFunder: UK Research and Innovation Project Code: EP/Z531066/1Funder Contribution: 11,782,400 GBPHowever, access to silicon prototyping facilities remains a challenge in the UK due to the high cost of both equipment and the cleanroom facilities that are required to house the equipment. Furthermore, there is often a disconnect in communication between industry and academia, resulting in some industrial challenges remaining unsolved, and support, training, and networking opportunities for academics to engage with commercialisation activities isn't widespread. The C-PIC host institutions comprising University of Southampton, University of Glasgow and the Science and Technologies Facilities Council (STFC), together with 105 partners at proposal stage, will overcome these challenges by uniting leading UK entrepreneurs and researchers, together with a network of support to streamline the route to commercialisation, translating a wide range of technologies from research labs into industry, underpinned by the C-PIC silicon photonics prototyping foundry. Applications will cover data centre communications; sensing for healthcare, the environment & defence; quantum technologies; artificial intelligence; LiDAR; and more. We will deliver our vision by fulfilling these objectives: Translate a wide range of silicon photonics technologies from research labs into industry, supporting the creation of new companies & jobs, and subsequently social & economic impact. Interconnect the UK silicon photonics ecosystem, acting as the front door to UK expertise, including by launching an online Knowledge Hub. Fund a broad range of Innovation projects supporting industrial-academic collaborations aimed at solving real world industry problems, with the overarching goal of demonstrating high potential solutions in a variety of application areas. Embed equality, diversity, and inclusion best practice into everything we do. Deliver the world's only open source, fully flexible silicon photonics prototyping foundry based on industry-like technology, facilitating straightforward scale-up to commercial viability. Support entrepreneurs in their journey to commercialisation by facilitating networks with venture capitalists, mentors, training, and recruitment. Represent the interests of the community at large with policy makers and the public, becoming an internationally renowned Centre able to secure overseas investment and international partners. Act as a convening body for the field in the UK, becoming a hub of skills, knowledge, and networking opportunities, with regular events aimed at ensuring possibilities for advancing the field and delivering impact are fully exploited. Increase the number of skilled staff working in impact generating roles in the field of silicon photonics via a range of training events and company growth, whilst routinely seeking additional funding to expand training offerings.
All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::5e73625cee4abc66457bd69afbfaffba&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eumore_vert All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::5e73625cee4abc66457bd69afbfaffba&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eu